| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/17/2007 | EP1844063A1 Purine nucleoside analogs |
| 10/17/2007 | EP1844042A1 Indole derivatives for treating viral infections |
| 10/17/2007 | EP1844037A1 Chemical compounds |
| 10/17/2007 | EP1844004A1 Quinazoline derivates as antiviral agents |
| 10/17/2007 | EP1843782A1 Method and use of interferon compositions for the treatment of avian influenza |
| 10/17/2007 | EP1843749A1 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 10/17/2007 | EP1648871B1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 10/17/2007 | EP1482911B1 Water dispersible mixture comprising complex carbohydrates from aloe vera and polyvinylpyrrolidone |
| 10/17/2007 | EP1474395B1 Nicotinamide derivates useful as p38 inhibitors |
| 10/17/2007 | EP1341769B1 Bacterial gyrase inhibitors and uses thereof |
| 10/17/2007 | EP1311289B1 Vaccines containing ribavirin |
| 10/17/2007 | EP1303291B1 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 10/17/2007 | EP1294892B1 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 10/17/2007 | EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 10/17/2007 | EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 10/17/2007 | EP1158990B1 Use of e5564 for the treatment of sepsis by intravenous infusion |
| 10/17/2007 | EP1144006B1 CCR5 Antibody PA14 |
| 10/17/2007 | EP1141728B1 Kidney disease detection and treatment |
| 10/17/2007 | CN101056981A Method for down-regulating gene expression in fungi |
| 10/17/2007 | CN101056887A Acylated nonadepsipeptides used as lysobactin derivatives |
| 10/17/2007 | CN101056673A Hydrochloride of 4-((4-(4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile |
| 10/17/2007 | CN101056648A Application of [d-meala]3- [etval]4 cyclosporin in treating hepatitis c infection and medicine composition containing [d-meala]3- [etval]4 cyclosporin |
| 10/17/2007 | CN101054584A 鱼类干扰素基因及其用途 Fish interferon gene and its use |
| 10/17/2007 | CN101054409A Amphiphilic short peptide and use thereof |
| 10/17/2007 | CN101054408A Method for separating housefly secretion type antibacterial peptide, product and application thereof |
| 10/17/2007 | CN101054393A Adefovir dipivoxil anhydrous crystal, preparation method and medicine composition thereof |
| 10/17/2007 | CN101054378A Entikawei potassium used for curing acute and chronic hepatic disease and preparation method thereof |
| 10/17/2007 | CN101054375A Compound capable of inhibiting tubercle bacillus growth and application thereof |
| 10/17/2007 | CN101054374A Flouroquinolone-oxazolidone derivative, composition, preparation method and application thereof |
| 10/17/2007 | CN101054344A Lipoxin A4 analogs |
| 10/17/2007 | CN101053658A H3 and H9 subtype influenza composite multiepitope bivalent DNA vaccine |
| 10/17/2007 | CN101053655A Preparing method for traditional Chinese medicine coptidis rhizome stir-fried with ginger juice |
| 10/17/2007 | CN101053614A Flesh and blood healing external applied anti-infectious powder and its medicine preparation |
| 10/17/2007 | CN101053612A External applied traditional Chinese medicine vagina cleaning agent for curing gynecopathy and vagina cleaning ointment thereof |
| 10/17/2007 | CN101053603A Fupo cold granules and preparation method thereof |
| 10/17/2007 | CN101053600A Medicinal composition for treating cough and preparation method and application thereof |
| 10/17/2007 | CN101053596A Supercritical carbon dioxide method for extracting high purity rhubarb free anthraquinones |
| 10/17/2007 | CN101053585A Preparation method and application for phyllanthus oral solid preparations |
| 10/17/2007 | CN101053584A Medicinal composition for treating chronic hepatitis and its preparation |
| 10/17/2007 | CN101053581A External applied medicine for treating tympanitis and preparation method thereof |
| 10/17/2007 | CN101053571A Gentiopicroside drop pill and preparation method thereof |
| 10/17/2007 | CN101053568A Compound and its processing technology for compound sulfamonomethoxine sodium injection |
| 10/17/2007 | CN101053565A Vaginal tablets containing coltrimazole |
| 10/17/2007 | CN101053560A Taurine and anti-infectious medicine composition |
| 10/17/2007 | CN101053556A Water soluble coenzyme Q10 hydroxyl-beta-cyclodextrin inclusion compound and its preparation method |
| 10/17/2007 | CN101053426A Piba honey juice beverage |
| 10/17/2007 | CN100343393C Central airway administration for systemic delivery of therapeutics |
| 10/17/2007 | CN100343282C Hybrid interferon compositions and methods of use |
| 10/17/2007 | CN100343268C Beta -2'-or 3'-halonucleosides |
| 10/17/2007 | CN100343266C Picrorhiza total glycoside extract and its application in preparation of liver disease medicine and preparation method |
| 10/17/2007 | CN100343260C Cephem compounds |
| 10/17/2007 | CN100343253C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors |
| 10/17/2007 | CN100343252C Novel imidazopyridine compounds with therapeutic effect |
| 10/17/2007 | CN100343249C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 10/17/2007 | CN100343223C Ester compound of thymol and/or carvacrol, preparing method and its medicinal active composition |
| 10/17/2007 | CN100343204C Forsythia seed extract and its prepn process |
| 10/17/2007 | CN100342912C Sustained release composition for oral administration of drugs |
| 10/17/2007 | CN100342911C Bivalent DNA vaccine of type A and type O foot-and-mouth disease virus and its preparing process |
| 10/17/2007 | CN100342909C Thymosin alpha-1 aqua prepn and its prepn process and application |
| 10/17/2007 | CN100342907C Treatment of aspergillus infections with thymosin alpha 1 |
| 10/17/2007 | CN100342874C Chinese medicine powder for treating viral hepatitis B and its preparation |
| 10/17/2007 | CN100342854C Cefadole oral liquor antibacterial composition |
| 10/17/2007 | CN100342850C Novel use of formaldehyde in preparation of drug for animals |
| 10/16/2007 | USRE39887 A cyclic depsipeptide from a tunicate of the Ascidiacea class; viricides, antitumor agents, immunosuppressants and cytotoxic agents |
| 10/16/2007 | US7282599 Administering dithiocarbamate compound having the structural formula R1R2NCS2H for therapy of infection by an RNA virus which attacks the respiratory tract and causes disease selected from picornavirus, ortho-myxovirus, rhinovirus, enterovirus, coxsackie virus, aphthovirus, or paramyxovirus |
| 10/16/2007 | US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 10/16/2007 | US7282504 Kinase inhibitors |
| 10/16/2007 | US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents |
| 10/16/2007 | US7282490 Osteopontin-related compositions and methods |
| 10/16/2007 | US7282486 A dosage form of pure crystalline azithromycin monohydrate hemi-ethanol solvate and a carrier or diluent; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of humans, mammals, birds and fish; drug resistance |
| 10/16/2007 | US7282368 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 10/16/2007 | US7282341 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time |
| 10/16/2007 | US7282216 Prepared by blending hydrophobic biocompatible, biodegradable polymers or copolymers, such as poly(lactide-co-glycolide), and a biocompatible, amphipathic copolymer having a water absorption ratio of 2 or less; sustained release drug delivery |
| 10/16/2007 | US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease |
| 10/16/2007 | US7282199 Genetic engineered polypeptide; inserted into cell; blood disorders |
| 10/16/2007 | CA2414018C 2-aminocarbonyl-9h-purine derivatives |
| 10/16/2007 | CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 10/16/2007 | CA2157375C Extraction of cell-bound protein from bordetella |
| 10/16/2007 | CA2124126C Monoclonal antibodies and fv specific for cd2 antigen |
| 10/14/2007 | CA2584894A1 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus |
| 10/11/2007 | WO2007114340A1 Pseudomonas aeruginosa outer membrane protein pa0427 |
| 10/11/2007 | WO2007114326A1 Novel compound having heterocyclic ring |
| 10/11/2007 | WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof |
| 10/11/2007 | WO2007113648A2 Ctla4 antibody combination therapy |
| 10/11/2007 | WO2007113538A1 Substituted adenines and the uses thereof |
| 10/11/2007 | WO2007113290A1 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
| 10/11/2007 | WO2007113256A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 10/11/2007 | WO2007113254A1 Hiv inhibiting 5-amido substituted pyrimidines |
| 10/11/2007 | WO2007113224A2 Conjugation process for pnag and a carrier protein |
| 10/11/2007 | WO2007113223A2 Immunogenic composition |
| 10/11/2007 | WO2007112966A1 Cellulose sulfate for the treatment of rhinovirus infection |
| 10/11/2007 | WO2007112835A2 Medicaments and/or food supplements comprising nisylene, cepa, euphrasia, belladonna and/or mercurius solubilis |
| 10/11/2007 | WO2007112828A1 Associations of xanthogenates and cyclodextrins, and their use |
| 10/11/2007 | WO2007112619A1 Oseltamivir phosphate granule and preparation mehtod thereof |
| 10/11/2007 | WO2007112567A1 Synthetic archaeal glycolipid adjuvants |
| 10/11/2007 | WO2007112518A1 Live attenuated salmonella vaccine |
| 10/11/2007 | WO2007106956A1 Live attenuated salmonella vaccine |
| 10/11/2007 | WO2007092888A3 Hcv ns5b inhibitors |
| 10/11/2007 | WO2007085760A3 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type |
| 10/11/2007 | WO2007085567A3 Synergistic compositions for treating hiv |